Rothschild & Co Redburn initiated coverage of Celestica Inc. on May 1, 2026, issuing a Buy rating for the company [1, 2].
This move signals a high-conviction bullish outlook from a major analyst team, contrasting with broader market forecasts that suggest a potential decline in the stock's value.
The analyst team at Rothschild & Co Redburn set a price target of $460 [1] for Celestica Inc., which is listed on the New York Stock Exchange under the ticker CLS [1, 2]. The firm identified the company as a strong-buy growth stock [1, 2].
This specific target stands in contrast to wider analyst sentiment recorded earlier this month. As of April 28, 2026, the average one-year price target for Celestica was $282 [2]. Based on those broader projections, some analysts forecast a 32.54% downside [2].
The discrepancy between the Rothschild & Co Redburn target and the market average highlights a significant divide in how analysts value the company's growth trajectory. While the average target suggests a contraction, the new coverage from Rothschild & Co Redburn suggests substantial upside potential [1, 2].
Celestica Inc. continues to be a focal point for investors tracking growth stocks on the NYSE, as new ratings shift the perceived valuation of the company's future earnings [1, 2].
“Rothschild & Co Redburn initiated coverage of Celestica Inc. on May 1, 2026, issuing a Buy rating”
The stark difference between the $460 target from Rothschild & Co Redburn and the $282 market average indicates a high level of volatility in analyst expectations for Celestica. If the bullish outlook proves accurate, it suggests that the firm sees growth catalysts that the broader market has either undervalued or ignored, potentially triggering a price correction upward.
